Gene expression differences among NMIBCs have been reported previously, and pathways relevant to tumor biology in bladder cancer are ERBB2, PI3K-AKT, cell cycle, MAPK, and DNA-damage repair. Here, ERBB2 is linked to urinary bladder cancer.